Reference
Health Canada. XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis. Internet Document : 2 Dec 2019. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71766a-eng.php
Rights and permissions
About this article
Cite this article
Risk of thrombosis with tofacitinib. Reactions Weekly 1783, 7 (2019). https://doi.org/10.1007/s40278-019-72490-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-72490-2